OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

NKTX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Nkarta (NKTX) Earnings Date & Reports

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NKTX is expected to report earnings to fall 17.60% to -35 cents per share on August 07

Q2'25

Est.

$-0.35

Q1'25

Beat

by $0.02

Q4'24

Beat

by $0.05

Q3'24

Missed

by $0.02

Q2'24

Beat

by $0.13

The last earnings report on May 14 showed earnings per share of -43 cents, beating the estimate of -44 cents. With 210.30K shares outstanding, the current market capitalization sits at 150.43M.

View a ticker or compare two or three

Compare

NKTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NKTX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1150 Veterans Boulevard

Phone

+1 905 407-1049

Employees

150

Web

https://www.nkartatx.com